ARIAD PHARMACEUTICALS INC Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARIAD PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARIAD PHARMACEUTICALS INC for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Panayiotopoulos Paris | President and CEO | Buy | P | 4.91 | 61,099 | 299,996 | 61,099 | 0 to 61.1 K |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 12,500 | 0 | 35,165 | 22.7 K to 35.2 K (+55.15 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | LAMARCHE JAY R | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | LAMARCHE JAY R | Director | Grant | A | 0.00 | 12,500 | 0 | 452,205 | 439.7 K to 452.2 K (+2.84 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | WILSON WAYNE | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | WILSON WAYNE | Director | Grant | A | 0.00 | 12,500 | 0 | 125,500 | 113 K to 125.5 K (+11.06 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | LAVIDAS ATHANESE | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | LAVIDAS ATHANESE | Director | Grant | A | 0.00 | 12,500 | 0 | 131,631 | 119.1 K to 131.6 K (+10.49 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Grant | A | 0.00 | 23,902 | 0 | 23,902 | 0 to 23.9 K |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Radaelli Massimo | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Radaelli Massimo | Director | Grant | A | 0.00 | 12,500 | 0 | 105,500 | 93 K to 105.5 K (+13.44 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Schlesinger Sarah J. | Director | Grant | A | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 12,500 | 0 | 121,859 | 109.4 K to 121.9 K (+11.43 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 29,333 | 0 | 29,333 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Sell | S | 4.81 | 14,667 | 70,578 | 79,414 | 94.1 K to 79.4 K (-15.59 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 29,333 | 0 | 94,081 | 64.7 K to 94.1 K (+45.30 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | M | 0.00 | 29,333 | 0 | 29,333 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Sell | S | 4.81 | 14,667 | 70,517 | 350,052 | 364.7 K to 350.1 K (-4.02 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Buy | M | 0.00 | 29,333 | 0 | 364,719 | 335.4 K to 364.7 K (+8.75 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Option Exercise | M | 0.00 | 29,333 | 0 | 29,333 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Sell | S | 4.81 | 14,667 | 70,548 | 141,463 | 156.1 K to 141.5 K (-9.39 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Buy | M | 0.00 | 29,333 | 0 | 156,130 | 126.8 K to 156.1 K (+23.13 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Option Exercise | M | 0.00 | 29,333 | 0 | 29,333 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Sell | S | 4.81 | 16,133 | 77,587 | 135,424 | 151.6 K to 135.4 K (-10.64 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Buy | M | 0.00 | 29,333 | 0 | 151,557 | 122.2 K to 151.6 K (+24.00 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Option Exercise | M | 0.00 | 29,333 | 0 | 29,333 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Sell | S | 4.81 | 14,667 | 70,515 | 250,115 | 264.8 K to 250.1 K (-5.54 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, Chief IP Couns ... | Buy | M | 0.00 | 29,333 | 0 | 264,782 | 235.4 K to 264.8 K (+12.46 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Option Exercise | M | 0.00 | 29,333 | 0 | 29,333 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Sell | S | 4.81 | 14,667 | 70,515 | 305,326 | 320 K to 305.3 K (-4.58 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Buy | M | 0.00 | 29,333 | 0 | 319,993 | 290.7 K to 320 K (+10.09 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Option Exercise | M | 0.00 | 29,333 | 0 | 29,333 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Sell | S | 4.81 | 14,667 | 70,517 | 123,117 | 137.8 K to 123.1 K (-10.64 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Sell | S | 4.93 | 1,466 | 7,227 | 137,784 | 139.3 K to 137.8 K (-1.05 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Buy | M | 0.00 | 29,333 | 0 | 139,250 | 109.9 K to 139.3 K (+26.69 %) |